HOWARD L. LANCE - 22 Jun 2021 Form 4 Insider Report for Change Healthcare Inc.

Role
Director
Signature
/s/ Carrie Ratliff, as Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
22 Jun 2021
Net transactions value
$0
Form type
4
Filing time
24 Jun 2021, 14:28:27 UTC
Previous filing
16 Jun 2021
Next filing
01 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CHNG Common Stock Award $0 +7,136 +3.4% $0.000000 218,856 22 Jun 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CHNG Stock Appreciation Right Award $0 +63,200 $0.000000 63,200 22 Jun 2021 Common Stock 63,200 $8.07 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the grant of deferred stock units that vests on June 22, 2022. The shares subject to the units will be issued to the Reporting Person after the Reporting Person's separation from service from the Issuer.
F2 Reflects the vesting of shares of 2.5x stock appreciation rights that were granted in connection with the Company's JV with McKesson as replacement awards for unvested exit-vesting Legacy CHC stock options. The shares of exit-vesting stock appreciation rights vested upon achievement of certain performance criteria on June 22, 2021.
F3 These stock appreciation rights are fully vested.